North America Intravenous Solutions Market Size & Outlook
North America intravenous solutions market, 2018-2030 (US$M)
Related Markets
North America intravenous solutions market highlights
- The North America intravenous solutions market generated a revenue of USD 5,276.9 million in 2023.
- The market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, total parenteral nutrition was the largest revenue generating product in 2023.
- Total Parenteral Nutrition is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 5,276.9 million |
| Market revenue in 2030 | USD 8,828.7 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Total parenteral nutrition |
| Fastest growing segment | Total Parenteral Nutrition |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Total Parenteral Nutrition, Peripheral Parenteral Nutrition |
| Key market players worldwide | Fresenius SE & Co KGaA, Fresenius Kabi, Pfizer Inc, Otsuka Pharmaceutical, Baxter International Inc, B. Braun, JW Life Sciences, CSL Ltd |
Other key industry trends
- In terms of revenue, North America region accounted for 41.0% of the global intravenous solutions market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,195.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Solutions Market Scope
Intravenous Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America intravenous solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous solutions market will help companies and investors design strategic landscapes.
Total parenteral nutrition was the largest segment with a revenue share of 66.83% in 2023. Horizon Databook has segmented the North America intravenous solutions market based on total parenteral nutrition, peripheral parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of a high number of malnourished children, high natality, increasing rate of premature births, growing prevalence of cancer, and rising adoption of intravenous (IV) parenteral nutrition products in healthcare settings for chronically ill geriatric patients are among the factors expected to drive the market.
Diseases such as Crohn’s disease, esophageal cancer, ulcerative colitis, gastric cancer, head & neck cancer, and laryngeal cancer affect oral food intake in patients. The growing prevalence of these diseases is expected to drive the demand for IV solution.
Increasing preference for home-based parenteral therapy has decreased the number of patient visits to hospitals & clinics. Increasing malnutrition is expected to further boost the demand for medical foods in this region.
Reasons to subscribe to North America intravenous solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America intravenous solutions market databook
-
Our clientele includes a mix of intravenous solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America intravenous solutions market , including forecasts for subscribers. This continent databook contains high-level insights into North America intravenous solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America intravenous solutions market size, by country, 2018-2030 (US$M)
North America Intravenous Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
